Now live: Pro — the full 13F research suite for serious investorsSee pricing →
← Tracker

Institutional

Clayton, Dubilier & Rice, LLC

CIK 0001538642
$895.0M
Reported AUM
2
Positions
Q2 2026
Period
2026-07-29
Filed

Editorial summary

Summary for Clayton, Dubilier & Rice, LLC · Q2 2026 is not yet generated. It will appear here after the next nightly run.

Portfolio · Q2 2026

REZI$466.2MAGL$428.7MCL

Top holdings

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1REZIResideo Technologies, Inc.$34.72-2.66%36.59%7.69%$466.2M52.10%HELD
2AGLAgilon Health, Inc.$96.754.41%127.65%-88.94%$428.7M47.90%HELD

Source: SEC EDGAR · accession 0001104659-26-087892. 13F discloses long positions only — shorts, foreign equities, and options are excluded.